Elke Holinski‐Feder

Risks of Less Common Cancers in Proven Mutation Carriers With Lynch Syndrome

Christoph Engel, Markus Loeffler, Verena Steinke et al. · Journal of Clinical Oncology · 2012 · 310 citations · Full text

Life Sciences, Genetics, Oncology +17

Lower Incidence of Colorectal Cancer and Later Age of Disease Onset in 27 Families With Pathogenic <i>MSH6</i> Germline Mutations Compared With Families With <i>MLH1</i> or <i>MSH2</i> Mutations: The German Hereditary Nonpolyposis Colorectal Cancer Consortium

Jens Plaschke, Christoph Engel, Stefan Krüger et al. · Journal of Clinical Oncology · 2004 · 245 citations · Full text

Life Sciences, Genetics, Oncology +17

Genotype-Phenotype Comparison of German <i>MLH1</i> and <i>MSH2</i> Mutation Carriers Clinically Affected With Lynch Syndrome: A Report by the German HNPCC Consortium

Timm O. Goecke, Karsten Schulmann, Christoph Engel et al. · Journal of Clinical Oncology · 2006 · 151 citations · Full text

Life Sciences, Genetics, Oncology +12

Distinction of Hereditary Nonpolyposis Colorectal Cancer and Sporadic Microsatellite-Unstable Colorectal Cancer through Quantification of MLH1 Methylation by Real-time PCR

Marcus Bettstetter, Stephan Dechant, Petra Ruemmele et al. · Clinical Cancer Research · 2007 · 97 citations

Medicine, Genetics, Oncology +17

DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2

Elke Holinski‐Feder, Y Müller-Koch, Waltraut Friedl et al. · Journal of Biochemical and Biophysical Methods · 2001 · 94 citations

Life Sciences, Genetics, Molecular Genetics +12